# Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis

> **NCT00655564** · PHASE4 · COMPLETED · sponsor: **Wake Forest University** · enrollment: 15 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Alefacept

## Key facts

- **NCT ID:** NCT00655564
- **Lead sponsor:** Wake Forest University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-12
- **Final completion:** 2010-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655564, "Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00655564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*